IBDEI0ZM ; ; 19-NOV-2015
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,16415,1,4,0)
 ;;=4^I35.8
 ;;^UTILITY(U,$J,358.3,16415,2)
 ;;=^5007177
 ;;^UTILITY(U,$J,358.3,16416,0)
 ;;=I77.6^^88^847^14
 ;;^UTILITY(U,$J,358.3,16416,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16416,1,3,0)
 ;;=3^Arteritis,Unspec
 ;;^UTILITY(U,$J,358.3,16416,1,4,0)
 ;;=4^I77.6
 ;;^UTILITY(U,$J,358.3,16416,2)
 ;;=^5007813
 ;;^UTILITY(U,$J,358.3,16417,0)
 ;;=I25.810^^88^847^15
 ;;^UTILITY(U,$J,358.3,16417,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16417,1,3,0)
 ;;=3^Atherosclerosis of CABG w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,16417,1,4,0)
 ;;=4^I25.810
 ;;^UTILITY(U,$J,358.3,16417,2)
 ;;=^5007141
 ;;^UTILITY(U,$J,358.3,16418,0)
 ;;=I70.91^^88^847^16
 ;;^UTILITY(U,$J,358.3,16418,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16418,1,3,0)
 ;;=3^Atherosclerosis,Generalized
 ;;^UTILITY(U,$J,358.3,16418,1,4,0)
 ;;=4^I70.91
 ;;^UTILITY(U,$J,358.3,16418,2)
 ;;=^5007785
 ;;^UTILITY(U,$J,358.3,16419,0)
 ;;=I70.90^^88^847^17
 ;;^UTILITY(U,$J,358.3,16419,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16419,1,3,0)
 ;;=3^Atherosclerosis,Unspec
 ;;^UTILITY(U,$J,358.3,16419,1,4,0)
 ;;=4^I70.90
 ;;^UTILITY(U,$J,358.3,16419,2)
 ;;=^5007784
 ;;^UTILITY(U,$J,358.3,16420,0)
 ;;=I25.10^^88^847^18
 ;;^UTILITY(U,$J,358.3,16420,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16420,1,3,0)
 ;;=3^Athscl Hrt Disease Native Coronary Artery w/o Angina Pectoris
 ;;^UTILITY(U,$J,358.3,16420,1,4,0)
 ;;=4^I25.10
 ;;^UTILITY(U,$J,358.3,16420,2)
 ;;=^5007107
 ;;^UTILITY(U,$J,358.3,16421,0)
 ;;=I48.91^^88^847^19
 ;;^UTILITY(U,$J,358.3,16421,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16421,1,3,0)
 ;;=3^Atrial Fibrillation,Unspec
 ;;^UTILITY(U,$J,358.3,16421,1,4,0)
 ;;=4^I48.91
 ;;^UTILITY(U,$J,358.3,16421,2)
 ;;=^5007229
 ;;^UTILITY(U,$J,358.3,16422,0)
 ;;=Z95.1^^88^847^21
 ;;^UTILITY(U,$J,358.3,16422,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16422,1,3,0)
 ;;=3^Bypass Graft,Aortocoronary
 ;;^UTILITY(U,$J,358.3,16422,1,4,0)
 ;;=4^Z95.1
 ;;^UTILITY(U,$J,358.3,16422,2)
 ;;=^5063669
 ;;^UTILITY(U,$J,358.3,16423,0)
 ;;=I78.9^^88^847^22
 ;;^UTILITY(U,$J,358.3,16423,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16423,1,3,0)
 ;;=3^Capillary Disease,Unspec
 ;;^UTILITY(U,$J,358.3,16423,1,4,0)
 ;;=4^I78.9
 ;;^UTILITY(U,$J,358.3,16423,2)
 ;;=^5007816
 ;;^UTILITY(U,$J,358.3,16424,0)
 ;;=I51.7^^88^847^23
 ;;^UTILITY(U,$J,358.3,16424,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16424,1,3,0)
 ;;=3^Cardiomegaly
 ;;^UTILITY(U,$J,358.3,16424,1,4,0)
 ;;=4^I51.7
 ;;^UTILITY(U,$J,358.3,16424,2)
 ;;=^5007257
 ;;^UTILITY(U,$J,358.3,16425,0)
 ;;=I42.1^^88^847^24
 ;;^UTILITY(U,$J,358.3,16425,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16425,1,3,0)
 ;;=3^Cardiomyopathy,Obstructive Hypertrophic
 ;;^UTILITY(U,$J,358.3,16425,1,4,0)
 ;;=4^I42.1
 ;;^UTILITY(U,$J,358.3,16425,2)
 ;;=^340520
 ;;^UTILITY(U,$J,358.3,16426,0)
 ;;=I42.2^^88^847^25
 ;;^UTILITY(U,$J,358.3,16426,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16426,1,3,0)
 ;;=3^Cardiomyopathy,Other Hypertrophic
 ;;^UTILITY(U,$J,358.3,16426,1,4,0)
 ;;=4^I42.2
 ;;^UTILITY(U,$J,358.3,16426,2)
 ;;=^340521
 ;;^UTILITY(U,$J,358.3,16427,0)
 ;;=Z13.6^^88^847^26
 ;;^UTILITY(U,$J,358.3,16427,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16427,1,3,0)
 ;;=3^Cardiovascular Disorder Screening
 ;;^UTILITY(U,$J,358.3,16427,1,4,0)
 ;;=4^Z13.6
 ;;^UTILITY(U,$J,358.3,16427,2)
 ;;=^5062707
 ;;^UTILITY(U,$J,358.3,16428,0)
 ;;=G45.1^^88^847^27
 ;;^UTILITY(U,$J,358.3,16428,1,0)
 ;;=^358.31IA^4^2
 ;;^UTILITY(U,$J,358.3,16428,1,3,0)
 ;;=3^Carotid Artery Syndrome
 ;;^UTILITY(U,$J,358.3,16428,1,4,0)
 ;;=4^G45.1
